{
    "id": "correct_foundationPlace_00052_2",
    "rank": 44,
    "data": {
        "url": "https://www.ohsu.edu/school-of-medicine/neurology",
        "read_more_link": "",
        "language": "en",
        "title": "Department of Neurology",
        "top_image": "https://www.ohsu.edu/themes/custom/ohsu_digs/favicon.ico",
        "meta_img": "https://www.ohsu.edu/themes/custom/ohsu_digs/favicon.ico",
        "images": [
            "https://www.ohsu.edu/sites/default/files/2021-02/2020_11_NEU_Liedtke_011_lutsep-225px.jpg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "Department of Neurology"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "The OHSU Department of Neurology is one of the nation’s leading neurologic research and training programs and provides the most comprehensive care of neurologic illnesses in the Pacific Northwest.",
        "meta_lang": "en",
        "meta_favicon": "/themes/custom/ohsu_digs/favicon.ico",
        "meta_site_name": "",
        "canonical_link": "https://www.ohsu.edu/school-of-medicine/neurology",
        "text": "OHSU 2023 accomplishments: The year in review\n\nEmma Chase and Vijayshree Yadav, M.D., Low-fat diet cuts fatigue in patients with multiple sclerosis (HealthDay, Dec. 15), Physicians Weekly, Neurology Advisor, OHSU News\n\nRegenerative brain cell therapy: One woman’s journey to seizure freedom (Cure Epilepsy podcast) and OHSU News (May 18)\n\nAndrew Natonson, M.D., More than half of commercial payers are denying coverage for lecanemab (Neurology Today, Dec. 7)\n\nEmma Chase and Vijayshree Yadav, M.D., Low-fat diet cuts fatigue in patients with multiple sclerosis (HealthDay, Dec. 15), Physicians Weekly, Neurology Advisor, OHSU News\n\nAndrew Natonson, M.D., More than half of commercial payers are denying coverage for lecanemab (Neurology Today, Dec. 7)\n\nAmala Soumyanath, Ph.D., What is ashwagandha? Doctors debate controversial ‘glizzy pills’ herbal supplement risks, benefits (The New York Post, Oct. 25) and How accurate are the claims about ashwagandha’s benefits? (Medical News Today)\n\nDennis Bourdette, M.D., Getting COVID raises odds for Guillain-Barre syndrome, vaccination lowers risk (U.S. News & World Report, Oct. 18)\n\nLisa Mann, R.N., The Great Salt Lick: 15 years of Whit Deschner’s creative philanthropy (OHSU Foundation, Oct. 11)\n\nKim Burchiel, M.D., and David Spencer, M.D., Doctors test experimental treatment to combat seizures in epilepsy patients (NBC News, Sept. 25), OHSU News\n\nLauren Talman, M.D., Neurologist discusses Parkinson’s treatment options (Hermiston Herald, Sept. 21)\n\nJonathan Elliott, Ph.D., and Miranda Lim, M.D., Ph.D., Lack of sex differences and high frequency of neurobiological abnormalities identified in REM sleep behavior disorder (NeurologyLive, Sept. 20)\n\nFay Horak, Ph.D., P.T., Here’s how exercise improves mobility of people with Parkinson’s disease (KATU, Sept. 15)\n\nGreat Salt Luck Auction returns to eastern Oregon (The Oregonian, Sept. 12)\n\nDelaram Safarpour, M.D., and Martina Mancini, Ph.D., Koneksa launches academic collaboration program for Parkinson’s disease (Business Wire, Aug. 14) and Oregon lab 1st to test 2 levodopa formulations using Koneksa’s toolkit (Parkinson’s News Today, Aug. 18)\n\nJoseph Quinn, M.D., As Alzheimer’s drugs hit the market, the race for early detection blood tests heats up (STAT, July 25)\n\nAimee Pierce, M.D., New Alzheimer’s drugs are coming. Here’s what you need to know (Science News, July 17)\n\nAmala Soumyanath, Ph.D., For some, this anti-anxiety herb is a godsend. For others, it’s a nightmare. What gives? (Salon, July 15)\n\nWalt Dawson, D.Phil., Viewpoint: Brain health diplomacy is a framework for the global challenge of brain health equity (OHSU News, July 11)\n\nLisa Silbert, M.D., Cognitive decline appears to speed up in the years following a heart attack (Neurology Today, July 6)\n\nLisa Silbert, M.D., Cognitive decline accelerates after heart attack, study finds (CNN, May 30)\n\nAmala Soumyanath, Ph.D., Here’s what experts say about using ashwagandha as a stress treatment (HuffPost, May 26)\n\nJeffrey Kaye, M.D., How will modern tech help us age in place? (Discover, May 26)\n\nAllison Lindauer, Ph.D., N.P., Brain changes are in the national spotlight, stigma and inaccuracy included (KUOW, May 18)\n\nFay Horak, Ph.D., P.T., Parkinson’s disease clinical trial tests exercise regimen to improve movement (OHSU News, May 16)\n\nPeter Spencer, Ph.D., They’re trying to cure nodding syndrome. First they need to zero in on the cause (NPR via Undark, May 2)\n\nAimee Pierce, M.D., Vancouver man’s Alzheimer’s experience offers hope, inspiration (The Columbian, March 2)\n\nBrain fog isn’t a formal medical diagnosis, but it can be debilitating. Here’s what you need to know (Livestrong.com, Feb. 26)\n\nHelmi Lutsep, M.D., Zaps to the spinal cord improved patients’ paralysis after stroke (The Wall Street Journal, Feb. 20)\n\nLindsey Wooliscroft, M.D., OHSU clinical trial tests exercise for multiple sclerosis treatment (OHSU News, Feb. 20)\n\nCaroline Tse, M.D., Doctors in the gray Northwest say getting some Vitamin D is a good idea (The Columbian, Feb. 7)\n\nLetisha Wyatt, Ph.D., Neuroscientists grapple with new data management rules (The Simons Foundation, Jan. 30)\n\nKristy Knight, M.S., C-C.C.-A., Based on OHSU research, FDA approves drug that reduces hearing loss in pediatric cancer patients (OPB Think Out Loud, Jan. 27) and Edward Neuwelt, M.D., and Leslie Muldoon, Ph.D., Driven by OHSU research, FDA approves new drug to prevent hearing loss in children with cancer (OHSU News, Jan. 17)\n\nEven simple motions make ripples across brain, study finds (University of Oregon, Jan. 27)"
    }
}